| 08/12/21 | 14:08:33 | 8 Dec 2021 | | Grant of Options | RNS |
| 07/12/21 | 07:00:02 | 7 Dec 2021 | | Half-year Report | RNS |
| 23/11/21 | 07:00:11 | 23 Nov 2021 | | Notice of Results | RNS |
| 10/11/21 | 07:00:06 | 10 Nov 2021 | | Publication of data on SFX-01 in glioblastoma | RNS |
| 19/10/21 | 14:39:16 | 19 Oct 2021 | | Holding(s) in Company | RNS |
| 20/09/21 | 07:00:09 | 20 Sept 2021 | | Publication of data in glioblastoma cells | RNS |
| 02/09/21 | 14:32:34 | 2 Sept 2021 | | Holding(s) in Company | RNS |
| 02/09/21 | 14:06:09 | 2 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 02/09/21 | 14:00:47 | 2 Sept 2021 | | Price Monitoring Extension | RNS |
| 02/09/21 | 11:05:40 | 2 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 02/09/21 | 11:01:52 | 2 Sept 2021 | | Glioma Orphan Drug designation granted by FDA | RNS |
| 02/09/21 | 11:00:34 | 2 Sept 2021 | | Price Monitoring Extension | RNS |
| 25/08/21 | 16:42:34 | 25 Aug 2021 | | Holding(s) in Company | RNS |
| 24/08/21 | 16:41:10 | 24 Aug 2021 | | Second Price Monitoring Extn | RNS |
| 24/08/21 | 16:36:08 | 24 Aug 2021 | | Price Monitoring Extension | RNS |
| 09/08/21 | 17:06:04 | 9 Aug 2021 | | Holding(s) in Company | RNS |
| 20/07/21 | 11:57:55 | 20 Jul 2021 | | Holding(s) in Company | RNS |
| 16/07/21 | 13:50:27 | 16 Jul 2021 | | Holding(s) in Company | RNS |
| 14/07/21 | 10:23:57 | 14 Jul 2021 | | Holding(s) in Company | RNS |
| 13/07/21 | 17:02:00 | 13 Jul 2021 | | Result of AGM and Business Update | RNS |
| 13/07/21 | 15:55:17 | 13 Jul 2021 | | Holding(s) in Company | RNS |
| 13/07/21 | 07:00:05 | 13 Jul 2021 | | Early data for SFX-01 in leukaemia cell lines | RNS |
| 13/07/21 | 07:00:02 | 13 Jul 2021 | | Glioma Orphan Drug application submitted to US FDA | RNS |
| 09/07/21 | 11:05:58 | 9 Jul 2021 | | Second Price Monitoring Extn | RNS |
| 09/07/21 | 11:00:36 | 9 Jul 2021 | | Price Monitoring Extension | RNS |
| 09/07/21 | 07:00:02 | 9 Jul 2021 | | Interim Safety and Futility Analysis - STAR trial | RNS |
| 18/06/21 | 07:00:05 | 18 Jun 2021 | | Posting of Annual Report and Notice of AGM | RNS |
| 15/06/21 | 07:00:06 | 15 Jun 2021 | | Final Results | RNS |
| 14/06/21 | 07:00:07 | 14 Jun 2021 | | Progress on metastatic breast cancer programme | RNS |
| 14/06/21 | 07:00:07 | 14 Jun 2021 | | Progress with Glioma/Glioblastoma programme | RNS |
| 26/04/21 | 07:00:06 | 26 Apr 2021 | | Appointment of Chief Medical Officer | RNS |
| 07/04/21 | 07:00:13 | 7 Apr 2021 | | Publication on sulforaphane in COVID-19 | RNS |
| 22/03/21 | 07:00:06 | 22 Mar 2021 | | Appointment of Chief Business Officer | RNS |
| 15/03/21 | 09:00:41 | 15 Mar 2021 | | Holding(s) in Company | RNS |
| 11/03/21 | 07:00:09 | 11 Mar 2021 | | Update on Data Safety Review - STAR COVID-19 trial | RNS |
| 09/03/21 | 11:35:15 | 9 Mar 2021 | | Holding(s) in Company | RNS |
| 08/03/21 | 13:49:25 | 8 Mar 2021 | | Holding(s) in Company | RNS |
| 05/03/21 | 16:04:30 | 5 Mar 2021 | | Holding(s) in Company | RNS |
| 05/03/21 | 09:17:12 | 5 Mar 2021 | | Director dealing | RNS |
| 03/03/21 | 12:10:31 | 3 Mar 2021 | | Result of General Meeting & Total Voting Rights | RNS |
| 03/03/21 | 07:00:07 | 3 Mar 2021 | | Result of Open Offer | RNS |
| 26/02/21 | 16:39:37 | 26 Feb 2021 | | Holding(s) in Company | RNS |
| 17/02/21 | 09:58:02 | 17 Feb 2021 | | Holding(s) in Company | RNS |
| 17/02/21 | 07:00:10 | 17 Feb 2021 | | Update on patient recruitment | RNS |
| 12/02/21 | 07:00:05 | 12 Feb 2021 | | Posting of Circular & Notice of GM | RNS |
| 02/02/21 | 15:15:32 | 2 Feb 2021 | | Placing and Open Offer to raise up to £11 million | RNS |
| 22/01/21 | 07:00:07 | 22 Jan 2021 | | Preclinical data on a new therapeutic target | RNS |
| 21/01/21 | 07:00:02 | 21 Jan 2021 | | Positive pre-clinical data for lead asset SFX-01 | RNS |
| 19/01/21 | 07:00:04 | 19 Jan 2021 | | Patient recruitment update in STAR-COVID 19 trial | RNS |
| 23/12/20 | 14:05:56 | 23 Dec 2020 | | Second Price Monitoring Extn | RNS |
